Stock TLT THERALASE TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Theralase Technologies Inc.

Equities

TLT

CA88337V1004

Market Closed - Toronto S.E.
Other stock markets
 15:50:24 2024-06-28 EDT 		5-day change 1st Jan Change
0.21 CAD +10.53% Intraday chart for Theralase Technologies Inc. +13.51% +20.00%
06-20 Theralase Technologies Inc. Announces Rutherrin Repurposes Non-Cancer Drugs for Cancer Therapy CI
06-12 Theralase Technologies Inc. Announces Rutherrin Increases Efficacy of Chemotherapy CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Theralase Technologies Inc. Announces Rutherrin Repurposes Non-Cancer Drugs for Cancer Therapy
CI
Theralase Technologies Inc. Announces Rutherrin Increases Efficacy of Chemotherapy
CI
Theralase Technologies Inc. Announces Ruvidar Enhances Efficacy of Cancer Drug
CI
Theralase Technologies Inc. Successfully Destroys Lung Cancer
CI
Theralase® Technology Effective in Virus Inactivation
CI
Theralase Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Theralase Technologies Inc. announced that it has received CAD 0.7502 million in funding
CI
Theralase Technologies Inc. Receives Canadian Cancer Vaccine Patent
CI
Theralase Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Theralase Technologies Donates Cool Laser Therapy Technology to Aid in R&D of Treatment for Parkinson's Disease
MT
Theralase Technologies shares update on Phase II Bladder Cancer study
AQ
Theralase Technologies Closes C$1.2-Million Private Placement of Share Units
MT
Theralase Technologies Inc. announced that it has received CAD 1.200001 million in funding
CI
Theralase Technologies Provides Update on Phase II Bladder Cancer Clinical Study
MT
Theralase Technologies Inc. Provides Update on Phase II Bladder Cancer Clinical Study
CI
Theralase makes positive progress on Phase II study on bladder cancer; targets breakthrough designation with FDA
AQ
Theralase Technologies Raises C$1.17 Million in a Private Placement of Share Units
MT
Theralase Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Theralase Technologies Inc. announced that it has received CAD 1.17 million in funding
CI
Theralase Technologies Raising up to C$1.5 Million in a Private Placement of Share Units
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TLT Stock
  4. News Theralase Technologies Inc.